Domainex (AgeTech UK) Biomed
Drug discovery services. Domainex is Europe's fastest growing drug discovery CRO. It serves pharmaceutical, biotechnology, academic and patient foundations globally. Domainex’s drug discovery service business was established in 2001 and since that time has continued to expand to serve a wider range of international clients including UCB, FORMA Therapeutics, St George’s University, and The Institute of Cancer Research.
Investor Type:
N/A
Technology:
AgeTech Companies
Investment Stage:
N/A
Founded Date:
N/A
Industry:
UK AgeTech 2020
Employee Number:
N/A
Funding Status:
N/A
Number Of Exists:
N/A
Headquarters:
United Kingdom